Semi-quantitative evaluation of CD44 +/CD24 - tumor cell distribution in breast cancer tissue using a newly developed fluorescence immunohistochemical staining method

Masaya Kai, Hideya Onishi, Masae Souzaki, Haruo Tanaka, Makoto Kubo, Masao Tanaka, Mitsuo Katano

Research output: Contribution to journalArticle

12 Citations (Scopus)

Abstract

CD44 +/CD24 - tumor cells are reported to contain cancer stem cells in breast cancer. The main purpose of the present study is to develop an immunohistofluorescence method that can quantitatively analyze CD44 +/CD24 - tumor cell distribution in breast cancer tissue and help better define the role of CD44 +/CD24 - tumor cells in breast cancer. The samples used were from 21 primary breast cancer patients who underwent neoadjuvant chemotherapy and 17 cases with sentinel lymph nodes that had lymph node micrometastasis. CD44 +/CD24 - tumor cells were distinguished at a single cell level using improved triple-staining immunohistofluorescence and a simulated laser capture microdissection method. The percentage of CD44 +/CD24 - cells significantly increased following neoadjuvant chemotherapy treatment (0.93% and 2.78%, before and after, respectively, P=0.0043). The percentage of CD44 +/CD24 - cells was also significantly high in micrometastatic sentinel lymph nodes (0.49% and 1.91%, primary tumors and lymph nodes, respectively, P=0.0246). The CD44 +/CD24 - tumor cell distribution was heterogeneous in both breast cancer tissue and lymph node metastasis. In a xenograft model using immunodeficient mice, the hedgehog signaling inhibitor cyclopamine repressed the tumorigenicity of CD44 +/CD24 - cells. Our results suggest that this semi-quantitative immunohistochemical analysis is valuable for detecting a small population of cells in cancer tissues and that the hedgehog signaling pathway inhibitor cyclopamine is useful for regulating the CD44 +/CD24 - tumor cells in breast cancer.

Original languageEnglish
Pages (from-to)2132-2138
Number of pages7
JournalCancer Science
Volume102
Issue number12
DOIs
Publication statusPublished - Dec 1 2011

Fingerprint

Fluorescence
Staining and Labeling
Breast Neoplasms
Neoplasms
Hedgehogs
Lymph Nodes
Laser Capture Microdissection
Drug Therapy
Neoplasm Micrometastasis
Neoadjuvant Therapy
Neoplastic Stem Cells
Heterografts
Neoplasm Metastasis
Population

All Science Journal Classification (ASJC) codes

  • Oncology
  • Cancer Research

Cite this

Semi-quantitative evaluation of CD44 +/CD24 - tumor cell distribution in breast cancer tissue using a newly developed fluorescence immunohistochemical staining method. / Kai, Masaya; Onishi, Hideya; Souzaki, Masae; Tanaka, Haruo; Kubo, Makoto; Tanaka, Masao; Katano, Mitsuo.

In: Cancer Science, Vol. 102, No. 12, 01.12.2011, p. 2132-2138.

Research output: Contribution to journalArticle

@article{9a43d21b75a54359be9a75dbc9bf8c99,
title = "Semi-quantitative evaluation of CD44 +/CD24 - tumor cell distribution in breast cancer tissue using a newly developed fluorescence immunohistochemical staining method",
abstract = "CD44 +/CD24 - tumor cells are reported to contain cancer stem cells in breast cancer. The main purpose of the present study is to develop an immunohistofluorescence method that can quantitatively analyze CD44 +/CD24 - tumor cell distribution in breast cancer tissue and help better define the role of CD44 +/CD24 - tumor cells in breast cancer. The samples used were from 21 primary breast cancer patients who underwent neoadjuvant chemotherapy and 17 cases with sentinel lymph nodes that had lymph node micrometastasis. CD44 +/CD24 - tumor cells were distinguished at a single cell level using improved triple-staining immunohistofluorescence and a simulated laser capture microdissection method. The percentage of CD44 +/CD24 - cells significantly increased following neoadjuvant chemotherapy treatment (0.93{\%} and 2.78{\%}, before and after, respectively, P=0.0043). The percentage of CD44 +/CD24 - cells was also significantly high in micrometastatic sentinel lymph nodes (0.49{\%} and 1.91{\%}, primary tumors and lymph nodes, respectively, P=0.0246). The CD44 +/CD24 - tumor cell distribution was heterogeneous in both breast cancer tissue and lymph node metastasis. In a xenograft model using immunodeficient mice, the hedgehog signaling inhibitor cyclopamine repressed the tumorigenicity of CD44 +/CD24 - cells. Our results suggest that this semi-quantitative immunohistochemical analysis is valuable for detecting a small population of cells in cancer tissues and that the hedgehog signaling pathway inhibitor cyclopamine is useful for regulating the CD44 +/CD24 - tumor cells in breast cancer.",
author = "Masaya Kai and Hideya Onishi and Masae Souzaki and Haruo Tanaka and Makoto Kubo and Masao Tanaka and Mitsuo Katano",
year = "2011",
month = "12",
day = "1",
doi = "10.1111/j.1349-7006.2011.02063.x",
language = "English",
volume = "102",
pages = "2132--2138",
journal = "Cancer Science",
issn = "1347-9032",
publisher = "Wiley-Blackwell",
number = "12",

}

TY - JOUR

T1 - Semi-quantitative evaluation of CD44 +/CD24 - tumor cell distribution in breast cancer tissue using a newly developed fluorescence immunohistochemical staining method

AU - Kai, Masaya

AU - Onishi, Hideya

AU - Souzaki, Masae

AU - Tanaka, Haruo

AU - Kubo, Makoto

AU - Tanaka, Masao

AU - Katano, Mitsuo

PY - 2011/12/1

Y1 - 2011/12/1

N2 - CD44 +/CD24 - tumor cells are reported to contain cancer stem cells in breast cancer. The main purpose of the present study is to develop an immunohistofluorescence method that can quantitatively analyze CD44 +/CD24 - tumor cell distribution in breast cancer tissue and help better define the role of CD44 +/CD24 - tumor cells in breast cancer. The samples used were from 21 primary breast cancer patients who underwent neoadjuvant chemotherapy and 17 cases with sentinel lymph nodes that had lymph node micrometastasis. CD44 +/CD24 - tumor cells were distinguished at a single cell level using improved triple-staining immunohistofluorescence and a simulated laser capture microdissection method. The percentage of CD44 +/CD24 - cells significantly increased following neoadjuvant chemotherapy treatment (0.93% and 2.78%, before and after, respectively, P=0.0043). The percentage of CD44 +/CD24 - cells was also significantly high in micrometastatic sentinel lymph nodes (0.49% and 1.91%, primary tumors and lymph nodes, respectively, P=0.0246). The CD44 +/CD24 - tumor cell distribution was heterogeneous in both breast cancer tissue and lymph node metastasis. In a xenograft model using immunodeficient mice, the hedgehog signaling inhibitor cyclopamine repressed the tumorigenicity of CD44 +/CD24 - cells. Our results suggest that this semi-quantitative immunohistochemical analysis is valuable for detecting a small population of cells in cancer tissues and that the hedgehog signaling pathway inhibitor cyclopamine is useful for regulating the CD44 +/CD24 - tumor cells in breast cancer.

AB - CD44 +/CD24 - tumor cells are reported to contain cancer stem cells in breast cancer. The main purpose of the present study is to develop an immunohistofluorescence method that can quantitatively analyze CD44 +/CD24 - tumor cell distribution in breast cancer tissue and help better define the role of CD44 +/CD24 - tumor cells in breast cancer. The samples used were from 21 primary breast cancer patients who underwent neoadjuvant chemotherapy and 17 cases with sentinel lymph nodes that had lymph node micrometastasis. CD44 +/CD24 - tumor cells were distinguished at a single cell level using improved triple-staining immunohistofluorescence and a simulated laser capture microdissection method. The percentage of CD44 +/CD24 - cells significantly increased following neoadjuvant chemotherapy treatment (0.93% and 2.78%, before and after, respectively, P=0.0043). The percentage of CD44 +/CD24 - cells was also significantly high in micrometastatic sentinel lymph nodes (0.49% and 1.91%, primary tumors and lymph nodes, respectively, P=0.0246). The CD44 +/CD24 - tumor cell distribution was heterogeneous in both breast cancer tissue and lymph node metastasis. In a xenograft model using immunodeficient mice, the hedgehog signaling inhibitor cyclopamine repressed the tumorigenicity of CD44 +/CD24 - cells. Our results suggest that this semi-quantitative immunohistochemical analysis is valuable for detecting a small population of cells in cancer tissues and that the hedgehog signaling pathway inhibitor cyclopamine is useful for regulating the CD44 +/CD24 - tumor cells in breast cancer.

UR - http://www.scopus.com/inward/record.url?scp=81855182181&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=81855182181&partnerID=8YFLogxK

U2 - 10.1111/j.1349-7006.2011.02063.x

DO - 10.1111/j.1349-7006.2011.02063.x

M3 - Article

C2 - 21838786

AN - SCOPUS:81855182181

VL - 102

SP - 2132

EP - 2138

JO - Cancer Science

JF - Cancer Science

SN - 1347-9032

IS - 12

ER -